According to Avadel Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.08. In 2022 the company made an earnings per share (EPS) of -$2.29 a decrease over its 2021 EPS that were of -$1.32.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.08 | -9.17% |
2022 | -$2.29 | 73.48% |
2021 | -$1.32 | -925% |
2020 | $0.16 | -117.98% |
2019 | -$0.89 | -65.1% |
2018 | -$2.55 | -256.44% |
2017 | $1.63 | -253.77% |
2016 | -$1.06 | -208.16% |
2015 | $0.98 | -139.68% |
2014 | -$2.47 | 46.15% |
2013 | -$1.69 | -3447.86% |
2012 | $0.05048 | -114.02% |
2011 | -$0.36 | -26.38% |
2010 | -$0.49 | 4.05% |
2009 | -$0.47 | -6% |
2008 | -$0.50 | -68.35% |
2007 | -$1.58 | 6.04% |
2006 | -$1.49 | 24.17% |
2005 | -$1.20 | -300% |
2004 | $0.60 | -287.5% |
2003 | -$0.32 | -1373.73% |
2002 | $0.02512 | -113.96% |
2001 | -$0.18 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -87.02% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -51.92% | ๐บ๐ธ USA |